More recent reviews and series have strengthened the evidence that somatic SLC35A2 mutations are not only recurrent but among the most frequent genetic alterations identified in otherwise non-lesional or subtly lesional focal epilepsies undergoing surgical evaluation [35,39]. The gene discussed is SLC35A2; the disease is focal epilepsy.